Follow the 딥노이드 share price and the full directors' dealings record of the company, a publicly traded company based in South Korea. Shares are listed on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 딥노이드 has logged 41 reports. Market capitalisation: €47bn. The latest transaction was reported on 21 May 2026 (Other). Among the most active insiders: 최우식. The full history is accessible without an account.
41
Insider Decl.
n/a
Thresholds
n/a
16 ops.
Buy Volume
n/a
1 ops.
Sell Volume
22Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 24,420 of 29,064 companies
27.5
score / 100
Value
12
Quality
43
FCF yld-14%
Earn yld-21%
EV/EBITDA·
ROE-55%
Gross mgn64%
Net mgn·
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Deepnoid is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on developing innovative solutions to enhance healthcare services.